How It Works
Core Ascent sits between companies with products or capital and the providers and buyers who need them. Every engagement runs on one of two tracks: financing facilitation, or commercialization and business development. Here is how each works, end to end.
Two very different kinds of clients come to Core Ascent. Providers and operators come with a deal that needs capital. Manufacturers and product companies come with a product that needs a market. The model below serves both, and the two tracks reinforce each other: the financing rail we run for the first group is the same rail we bolt onto product offers for the second.
An equipment purchase, an expansion, working capital, an acquisition. One conversation covers what you are financing, the rough numbers, and where the business stands today.
We assemble one complete deal file: the financials, the story, the structure that makes sense. You tell it once, to us, instead of repeating it to every institution you can find.
No single source fits every deal, so we route each deal to the rail that fits: equipment financing, business term structures, or a combination. Credit decisions are made by our capital partners and are subject to underwriting.
Offers come back, you compare the structures side by side, choose the one that fits the business, and close. We stay on the file through funding.
Explore equipment and business financing at coreascent.finance →
Financing and commercialization run through the same team, so a product launch and its financing rail arrive as one offer, not two vendors.
A manufacturer or product company arrives with something ready for market: a clinical device platform, an equipment category, a service offer that needs distribution.
Distribution agreements, rep coverage, provider onboarding. We build the route from your product to the providers and buyers who need it, and we manage that channel as it grows.
The same capital partner rails from track one attach to the offer, so a buyer sees the product and a way to pay for it in the same conversation. That is what moves a good product from interest to purchase order.
Commercializing a clinical device line, in neurostimulation or another category? Talk to us about clinical device distribution.
Core Ascent is compensated by its capital and product partners on funded and completed transactions. When a deal funds on a capital partner rail, the capital partner compensates us. When product moves through a channel we built, the product partner compensates us.
That structure keeps our incentives pointed the right way: we are paid on outcomes, not activity, so the only work worth our time is work that actually closes. And to be plain about what we are not: Core Ascent is a facilitator, not a lender or broker. Capital comes from third-party capital partners, and credit decisions are made by those partners, subject to underwriting.
Trust & Disclosures
